Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ishita Agrawal, Pallavi Tripathi & Shyamasri Biswas. (2022) Mass spectrometry based protein biomarkers and drug target discovery and clinical diagnosis in Age-Related progressing neurodegenerative diseases. Drug Metabolism Reviews 54:1, pages 22-36.
Read now
Read now
Alexander G Thompson, Patrick Oeckl, Emily Feneberg, Robert Bowser, Markus Otto, Roman Fischer, Benedikt Kessler & Martin R Turner. (2021) Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis. Expert Review of Proteomics 18:11, pages 977-994.
Read now
Read now
Sandra Murphy, Margit Zweyer, Rustam R. Mundegar, Dieter Swandulla & Kay Ohlendieck. (2018) Proteomic serum biomarkers for neuromuscular diseases. Expert Review of Proteomics 15:3, pages 277-291.
Read now
Read now
Articles from other publishers (24)
Soju Seki, Yoshihiro Kitaoka, Sou Kawata, Akira Nishiura, Toshihiro Uchihashi, Shin-ichiro Hiraoka, Yusuke Yokota, Emiko Tanaka Isomura, Mikihiko Kogo & Susumu Tanaka. (2023) Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy. Biomedicines 11:11, pages 2967.
Crossref
Crossref
Sungtaek Oh, Yura Jang & Chan Hyun Na. (2023) Discovery of Biomarkers for Amyotrophic Lateral Sclerosis from Human Cerebrospinal Fluid Using Mass-Spectrometry-Based Proteomics. Biomedicines 11:5, pages 1250.
Crossref
Crossref
Xu Chen, Lu Zhou, Can Cui & Jiangwei Sun. 2023.
225
246
.
Jared S. Katzeff, Fiona Bright, Katherine Phan, Jillian J. Kril, Lars M. Ittner, Michael Kassiou, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday & Woojin Scott Kim. (2022) Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain 145:5, pages 1598-1609.
Crossref
Crossref
Feng Wang, Shan Li, Kai-Wen Cheng, William M. Rosencrans & Tsui-Fen Chou. (2022) The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation. Pharmaceuticals 15:2, pages 204.
Crossref
Crossref
Cory J. Holdom, Frederik J. Steyn, Robert D. Henderson, Pamela A. McCombe, Mary-Louise Rogers & Shyuan T. Ngo. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers
263
306
.
Koy Chong Ng Kee Kwong, Pratap K. Harbham, Bhuvaneish T. Selvaraj, Jenna M. Gregory, Suvankar Pal, Giles E. Hardingham, Siddharthan Chandran & Arpan R. Mehta. (2021) 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?. Frontiers in Molecular Neuroscience 14.
Crossref
Crossref
Xiaojun Zhang, Lin Yin, Xiaofang Jia, Yujiao Zhang, Tiefu Liu & Lijun Zhang. (2021) iTRAQ-based Quantitative Proteomic Analysis of Dural Tissues Reveals Upregulated Haptoglobin to be a Potential Biomarker of Moyamoya Disease. Current Proteomics 18:1, pages 27-37.
Crossref
Crossref
Koy Chong Ng Kee Kwong, Arpan R. Mehta, Maiken Nedergaard & Siddharthan Chandran. (2020) Defining novel functions for cerebrospinal fluid in ALS pathophysiology. Acta Neuropathologica Communications 8:1.
Crossref
Crossref
Giovanna Morello, Salvatore Salomone, Velia D’Agata, Francesca Luisa Conforti & Sebastiano Cavallaro. (2020) From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 14.
Crossref
Crossref
Jared S. Katzeff, Fiona Bright, Kitty Lo, Jillian J. Kril, Angela Connolly, Ben Crossett, Lars M. Ittner, Michael Kassiou, Clement T. Loy, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday & Woojin Scott Kim. (2020) Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation. Scientific Reports 10:1.
Crossref
Crossref
Suofeng Sun, Huijuan Zhang, Yu Wang, Jing Gao, Shen Zhou, Yuan Li, Shuangyin Han, Xiuling Li & Jian Li. (2020) Proteomic Analysis of Human Esophageal Cancer Using Tandem Mass Tag Quantifications. BioMed Research International 2020, pages 1-8.
Crossref
Crossref
Koy Chong Ng Kee Kwong, Jenna M Gregory, Suvankar Pal, Siddharthan Chandran & Arpan R Mehta. (2020) Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies. Brain Communications 2:2.
Crossref
Crossref
Jing Tang, Jianbo Fu, Yunxia Wang, Bo Li, Yinghong Li, Qingxia Yang, Xuejiao Cui, Jiajun Hong, Xiaofeng Li, Yuzong Chen, Weiwei Xue & Feng Zhu. (2020) ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies. Briefings in Bioinformatics 21:2, pages 621-636.
Crossref
Crossref
Katerina Kadena & Panayiotis Vlamos. 2020. GeNeDis 2018. GeNeDis 2018
179
187
.
Jianbo Fu, Yongchao Luo, Minjie Mou, Hongning Zhang, Jing Tang, Yunxia Wang & Feng Zhu. (2019) Advances in Current Diabetes Proteomics: From the Perspectives of Label- free Quantification and Biomarker Selection. Current Drug Targets 21:1, pages 34-54.
Crossref
Crossref
William R. Swindell, Colin P. S. Kruse, Edward O. List, Darlene E. Berryman & John J. Kopchick. (2019) ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia. Journal of Translational Medicine 17:1.
Crossref
Crossref
Jing Tang, Jianbo Fu, Yunxia Wang, Yongchao Luo, Qingxia Yang, Bo Li, Gao Tu, Jiajun Hong, Xuejiao Cui, Yuzong Chen, Lixia Yao, Weiwei Xue & Feng Zhu. (2019) Simultaneous Improvement in the Precision, Accuracy, and Robustness of Label-free Proteome Quantification by Optimizing Data Manipulation Chains*. Molecular & Cellular Proteomics 18:8, pages 1683-1699.
Crossref
Crossref
Thomas J. Hedl, Rebecca San Gil, Flora Cheng, Stephanie L. Rayner, Jennilee M. Davidson, Alana De Luca, Maria D. Villalva, Heath Ecroyd, Adam K. Walker & Albert Lee. (2019) Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD. Frontiers in Neuroscience 13.
Crossref
Crossref
Laura Moreno-Martinez, Ana Cristina Calvo, María Jesús Muñoz & Rosario Osta. (2019) Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?. International Journal of Molecular Sciences 20:11, pages 2759.
Crossref
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Crossref
Maria-Letizia Campanari, Annis-Rayan Bourefis & Edor Kabashi. (2019) Diagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis. Frontiers in Neurology 10.
Crossref
Crossref
Patrick A. Lewis & Jennifer E. Spillane. 2019. The Molecular and Clinical Pathology of Neurodegenerative Disease. The Molecular and Clinical Pathology of Neurodegenerative Disease
157
191
.
Konstantinos MitropoulosTheodora KatsilaGeorge P. PatrinosGeorgios Pampalakis. (2018) Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis. OMICS: A Journal of Integrative Biology 22:1, pages 52-64.
Crossref
Crossref